rs727503249
Variant summary
Our verdict is Pathogenic. The variant received 10 ACMG points: 10P and 0B. PM2PM5PP2PP3_StrongPP5
The NM_000257.4(MYH7):c.3748C>T(p.Arg1250Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000137 in 1,461,874 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1250G) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000257.4 missense
Scores
Clinical Significance
Conservation
Publications
- dilated cardiomyopathyInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- dilated cardiomyopathy 1SInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
- hypertrophic cardiomyopathyInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- hypertrophic cardiomyopathy 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
- MYH7-related skeletal myopathyInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), ClinGen, Ambry Genetics
- myopathy, myosin storage, autosomal recessiveInheritance: AR Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
- myopathy, myosin storage, autosomal dominantInheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
- congenital myopathy 7A, myosin storage, autosomal dominantInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Ebstein anomalyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- familial isolated dilated cardiomyopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- hyaline body myopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- left ventricular noncompactionInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- arrhythmogenic right ventricular cardiomyopathyInheritance: AD Classification: LIMITED Submitted by: ClinGen
- congenital heart diseaseInheritance: AD Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 10 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000257.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| MYH7 | NM_000257.4 | MANE Select | c.3748C>T | p.Arg1250Trp | missense | Exon 28 of 40 | NP_000248.2 | ||
| MYH7 | NM_001407004.1 | c.3748C>T | p.Arg1250Trp | missense | Exon 27 of 39 | NP_001393933.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| MYH7 | ENST00000355349.4 | TSL:1 MANE Select | c.3748C>T | p.Arg1250Trp | missense | Exon 28 of 40 | ENSP00000347507.3 | ||
| MYH7 | ENST00000713768.1 | c.3748C>T | p.Arg1250Trp | missense | Exon 28 of 41 | ENSP00000519070.1 | |||
| MYH7 | ENST00000713769.1 | c.3748C>T | p.Arg1250Trp | missense | Exon 27 of 39 | ENSP00000519071.1 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1461874Hom.: 0 Cov.: 45 AF XY: 0.00 AC XY: 0AN XY: 727238 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
Left ventricular noncompaction Pathogenic:1
The Arg1250Trp variant in MYH7 has been reported in 1 African American adult wit h LVNC and segregated with disease in 3 affected relatives (Dellefave 2009, LMM unpublished). It was absent from large population studies. Arginine (Arg) at pos ition 1250 is highly conserved in evolution and the change to tryptophan (Trp) w as predicted to be pathogenic using a computational tool clinically validated by our laboratory. This tool's pathogenic prediction is estimated to be correct 94 % of the time (Jordan 2011). In summary, although additional studies are require d to fully establish its clinical significance, the Arg1250Trp variant is likely pathogenic.
Hypertrophic cardiomyopathy Pathogenic:1
This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 1250 of the MYH7 protein (p.Arg1250Trp). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with dilated cardiomyopathy and/or left ventricular noncompaction (PMID: 20031619, 20965760; internal data). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 164299). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt MYH7 protein function with a positive predictive value of 95%. For these reasons, this variant has been classified as Pathogenic.
not specified Uncertain:1
Variant summary: MYH7 c.3748C>T (p.Arg1250Trp) results in a non-conservative amino acid change located in the Myosin tail domain (IPR002928) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 251332 control chromosomes (gnomAD). c.3748C>T has been reported in the literature in three individuals affected with Cardiomyopathy and the variant segregated with disease in this family (example: Dellefave_2009). To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Two clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 and classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as uncertain significance.
Cardiomyopathy Uncertain:1
This missense variant replaces arginine with tryptophan at codon 1250 of the MYH7 protein. Computational prediction tools indicate that this variant has a deleterious impact on protein structure and function. To our knowledge, functional studies have not been reported for this variant. This variant has been reported in at least two individuals affected with dilated cardiomyopathy (PMID: 20031619, 35284542). It has been shown that this variant segregates with disease in three affected individuals from one family (PMID: 20031619). This variant has also been reported in one individual affected with left ventricular noncompaction (PMID: 20965760). This variant has not been identified in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance.
not provided Uncertain:1
Not observed in large population cohorts (Lek et al., 2016); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; This variant is associated with the following publications: (PMID: 27066506, 20031619)
Cardiovascular phenotype Uncertain:1
The p.R1250W variant (also known as c.3748C>T), located in coding exon 26 of the MYH7 gene, results from a C to T substitution at nucleotide position 3748. The arginine at codon 1250 is replaced by tryptophan, an amino acid with dissimilar properties. This variant was identified in an individual with a dilated heart and noncompaction and in two of his relatives reported to have dilated cardiomyopathy (DCM) (Dellefave LM et al. Circ Cardiovasc Genet, 2009 Oct;2:442-9). This variant has also been reported in hypertrophic cardiomyopathy (HCM), DCM and biobank cohorts (Shen C et al. Ann Transl Med, 2022 Feb;10:129; Daoud H et al. J Mol Diagn, 2019 May;21:437-448; Wright CF et al. Am J Hum Genet, 2019 Feb;104:275-286; Puckelwartz MJ et al. J Am Heart Assoc, 2021 Apr;10:e019944). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at